Skip to main content
Erschienen in: European Radiology 8/2014

01.08.2014 | Magnetic Resonance

Image quality and cancer visibility of T2-weighted Magnetic Resonance Imaging of the prostate at 7 Tesla

verfasst von: E. K. Vos, M. W. Lagemaat, J. O. Barentsz, J. J. Fütterer, P. Zámecnik, H. Roozen, S. Orzada, A. K. Bitz, M. C. Maas, T. W. J. Scheenen

Erschienen in: European Radiology | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To assess the image quality of T2-weighted (T2w) magnetic resonance imaging of the prostate and the visibility of prostate cancer at 7 Tesla (T).

Materials & methods

Seventeen prostate cancer patients underwent T2w imaging at 7T with only an external transmit/receive array coil. Three radiologists independently scored images for image quality, visibility of anatomical structures, and presence of artefacts. Krippendorff’s alpha and weighted kappa statistics were used to assess inter-observer agreement. Visibility of prostate cancer lesions was assessed by directly linking the T2w images to the confirmed location of prostate cancer on histopathology.

Results

T2w imaging at 7T was achievable with ‘satisfactory’ (3/5) to ‘good’ (4/5) quality. Visibility of anatomical structures was predominantly scored as ‘satisfactory’ (3/5) and ‘good’ (4/5). If artefacts were present, they were mostly motion artefacts and, to a lesser extent, aliasing artefacts and noise. Krippendorff’s analysis revealed an α = 0.44 between three readers for the overall image quality scores. Clinically significant cancer lesions in both peripheral zone and transition zone were visible at 7T.

Conclusion

T2w imaging with satisfactory to good quality can be routinely acquired, and cancer lesions were visible in patients with prostate cancer at 7T using only an external transmit/receive body array coil.

Key Points

Satisfactory to good T2-weighted image quality of the prostate is achievable at 7T.
Periprostatic lipids appear hypo-intense compared to healthy peripheral zone tissue at 7T.
Prostate cancer is visible on T2-weighted MRI at 7T.
Literatur
1.
Zurück zum Zitat Hoeks CMA, Barentsz JO, Hambrock T, Yakar D, Somford DM, Heijmink SWTPJ et al (2011) Prostate cancer: multiparametric mr imaging for detection, localization, and staging. Radiology 261(1):46–66PubMedCrossRef Hoeks CMA, Barentsz JO, Hambrock T, Yakar D, Somford DM, Heijmink SWTPJ et al (2011) Prostate cancer: multiparametric mr imaging for detection, localization, and staging. Radiology 261(1):46–66PubMedCrossRef
2.
Zurück zum Zitat Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Fütterer JJ et al (2011) Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 59(4):477–494PubMedCrossRef Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Fütterer JJ et al (2011) Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 59(4):477–494PubMedCrossRef
3.
Zurück zum Zitat Shukla-Dave A, Hricak H (2014) Role of MRI in prostate cancer detection. NMR Biomed 27(1):16–24PubMedCrossRef Shukla-Dave A, Hricak H (2014) Role of MRI in prostate cancer detection. NMR Biomed 27(1):16–24PubMedCrossRef
4.
Zurück zum Zitat Lagemaat MW, Scheenen TWJ (2014) Role of high-field MR in studies of localized prostate cancer. NMR Biomed 27(1):67–79PubMedCrossRef Lagemaat MW, Scheenen TWJ (2014) Role of high-field MR in studies of localized prostate cancer. NMR Biomed 27(1):67–79PubMedCrossRef
5.
Zurück zum Zitat Isebaert S, Van den Bergh L, Haustermans K, Joniau S, Lerut E, De Wever L et al (2013) Multiparametric MRI for prostate cancer localization in correlation to whole-mount histopathology. J Magn Reson Imaging 37(6):1392–1401PubMedCrossRef Isebaert S, Van den Bergh L, Haustermans K, Joniau S, Lerut E, De Wever L et al (2013) Multiparametric MRI for prostate cancer localization in correlation to whole-mount histopathology. J Magn Reson Imaging 37(6):1392–1401PubMedCrossRef
6.
Zurück zum Zitat Arumainayagam N, Ahmed HU, Moore CM, Freeman A, Allen C, Sohaib SA et al (2013) Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation Cohort study with transperineal template prostate mapping as the reference standard. Radiology 268(3):761–769PubMedCrossRef Arumainayagam N, Ahmed HU, Moore CM, Freeman A, Allen C, Sohaib SA et al (2013) Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation Cohort study with transperineal template prostate mapping as the reference standard. Radiology 268(3):761–769PubMedCrossRef
7.
Zurück zum Zitat Soylu FN, Peng Y, Jiang Y, Wang S, Schmid-Tannwald C, Sethi I et al (2013) Seminal vesicle invasion in prostate cancer: evaluation by using multiparametric endorectal MR imaging. Radiology 267(3):797–806PubMedCrossRef Soylu FN, Peng Y, Jiang Y, Wang S, Schmid-Tannwald C, Sethi I et al (2013) Seminal vesicle invasion in prostate cancer: evaluation by using multiparametric endorectal MR imaging. Radiology 267(3):797–806PubMedCrossRef
8.
Zurück zum Zitat Donati OF, Jung SI, Vargas HA, Gultekin DH, Zheng J, Moskowitz CS et al (2013) Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy? Radiology 268(2):440–450PubMedCrossRef Donati OF, Jung SI, Vargas HA, Gultekin DH, Zheng J, Moskowitz CS et al (2013) Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy? Radiology 268(2):440–450PubMedCrossRef
9.
Zurück zum Zitat Roethke MC, Kuru TH, Schultze S, Tichy D, Kopp-Schneider A, Fenchel M et al (2014) Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla. Eur Radiol 24(2):344–352PubMedCrossRef Roethke MC, Kuru TH, Schultze S, Tichy D, Kopp-Schneider A, Fenchel M et al (2014) Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla. Eur Radiol 24(2):344–352PubMedCrossRef
10.
11.
Zurück zum Zitat Kobus T, Bitz AK, van Uden MJ, Lagemaat MW, Rothgang E, Orzada S et al (2012) In Vivo (31) P MR spectroscopic imaging of the human prostate at 7 T: safety and feasibility. Magn Reson Med 68(6):1683–1695PubMedCrossRef Kobus T, Bitz AK, van Uden MJ, Lagemaat MW, Rothgang E, Orzada S et al (2012) In Vivo (31) P MR spectroscopic imaging of the human prostate at 7 T: safety and feasibility. Magn Reson Med 68(6):1683–1695PubMedCrossRef
12.
Zurück zum Zitat Metzger GJ, Snyder C, Akgun C, Vaughan T, Ugurbil K, Van de Moortele PF (2008) Local B1+ shimming for prostate imaging with transceiver arrays at 7T based on subject-dependent transmit phase measurements. Magn Reson Med 59(2):396–409PubMedCrossRef Metzger GJ, Snyder C, Akgun C, Vaughan T, Ugurbil K, Van de Moortele PF (2008) Local B1+ shimming for prostate imaging with transceiver arrays at 7T based on subject-dependent transmit phase measurements. Magn Reson Med 59(2):396–409PubMedCrossRef
13.
Zurück zum Zitat de Bazelaire CMJ, Duhamel GD, Rofsky NM, Alsop DC (2004) MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 230(3):652–659PubMedCrossRef de Bazelaire CMJ, Duhamel GD, Rofsky NM, Alsop DC (2004) MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 230(3):652–659PubMedCrossRef
14.
Zurück zum Zitat Maas MC, Vos EK, Lagemaat MW, Bitz AK, Orzada S, Kobus T et al (2014) Feasibility of T2 -weighted turbo spin echo imaging of the human prostate at 7 tesla. Magn Reson Med 71(5):1711–1719PubMedCrossRef Maas MC, Vos EK, Lagemaat MW, Bitz AK, Orzada S, Kobus T et al (2014) Feasibility of T2 -weighted turbo spin echo imaging of the human prostate at 7 tesla. Magn Reson Med 71(5):1711–1719PubMedCrossRef
15.
Zurück zum Zitat Orzada S, Quick HH, Ladd ME, Bahr A, Bolz T, Yazdanbakhsh P et al (2009) A flexible 8-channel transmit/receive body coil for 7 T human imaging. Proc Intl Soc Mag Reson Med 17(2999) Orzada S, Quick HH, Ladd ME, Bahr A, Bolz T, Yazdanbakhsh P et al (2009) A flexible 8-channel transmit/receive body coil for 7 T human imaging. Proc Intl Soc Mag Reson Med 17(2999)
16.
Zurück zum Zitat Lagemaat MW, Vos EK, Maas MC, Bitz AK, Orzada S, van Uden MJ et al (2014) Phosphorus magnetic resonance spectroscopic imaging at 7 T in patients with prostate cancer. Invest Radiol 49(5):363–372PubMedCrossRef Lagemaat MW, Vos EK, Maas MC, Bitz AK, Orzada S, van Uden MJ et al (2014) Phosphorus magnetic resonance spectroscopic imaging at 7 T in patients with prostate cancer. Invest Radiol 49(5):363–372PubMedCrossRef
17.
Zurück zum Zitat Yakar D, Hambrock T, Hoeks C, Barentsz JO, Fütterer JJ (2008) Magnetic resonance-guided biopsy of the prostate: feasibility, technique, and clinical applications. Top Magn Reson Imaging 19(6):291–295PubMedCrossRef Yakar D, Hambrock T, Hoeks C, Barentsz JO, Fütterer JJ (2008) Magnetic resonance-guided biopsy of the prostate: feasibility, technique, and clinical applications. Top Magn Reson Imaging 19(6):291–295PubMedCrossRef
18.
Zurück zum Zitat Bratan F, Niaf E, Melodelima C, Chesnais AL, Souchon R, Mège-Lechevallier F et al (2013) Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study. Eur Radiol 23(7):2019–2029PubMedCrossRef Bratan F, Niaf E, Melodelima C, Chesnais AL, Souchon R, Mège-Lechevallier F et al (2013) Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study. Eur Radiol 23(7):2019–2029PubMedCrossRef
19.
Zurück zum Zitat Vargas HA, Akin O, Shukla-Dave A, Zhang J, Zakian KL, Zheng J et al (2012) Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study. Radiology 265(2):478–487PubMedCentralPubMedCrossRef Vargas HA, Akin O, Shukla-Dave A, Zhang J, Zakian KL, Zheng J et al (2012) Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study. Radiology 265(2):478–487PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Metzger GJ, van de Moortele PF, Akgun C, Snyder CJ, Moeller S, Strupp J et al (2010) Performance of external and internal coil configurations for prostate investigations at 7 T. Magn Reson Med 64(6):1625–1639PubMedCentralPubMedCrossRef Metzger GJ, van de Moortele PF, Akgun C, Snyder CJ, Moeller S, Strupp J et al (2010) Performance of external and internal coil configurations for prostate investigations at 7 T. Magn Reson Med 64(6):1625–1639PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Weigel M, Hennig J (2006) Contrast behavior and relaxation effects of conventional and hyperecho-turbo spin echo sequences at 1.5 and 3 T. Magn Reson Med 55(4):826–835PubMedCrossRef Weigel M, Hennig J (2006) Contrast behavior and relaxation effects of conventional and hyperecho-turbo spin echo sequences at 1.5 and 3 T. Magn Reson Med 55(4):826–835PubMedCrossRef
Metadaten
Titel
Image quality and cancer visibility of T2-weighted Magnetic Resonance Imaging of the prostate at 7 Tesla
verfasst von
E. K. Vos
M. W. Lagemaat
J. O. Barentsz
J. J. Fütterer
P. Zámecnik
H. Roozen
S. Orzada
A. K. Bitz
M. C. Maas
T. W. J. Scheenen
Publikationsdatum
01.08.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 8/2014
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-014-3234-6

Weitere Artikel der Ausgabe 8/2014

European Radiology 8/2014 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.